Introduction
The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. While Datamonitor’s updated forecast will parallel its previous forecast up to 2012, several new product launches, regional expansion and upgraded brand forecast will help to sustain growth in the second half of the forecast period.
Reasons to Purchase
*Understand how new brands Lialda and Apriso will fare against established market players, such as Asacol and Pentasa
*Assess the impact of the launch of Cimzia’s recent pre-filled syringe and gauge future dynamics within the anti-TNF class
*Quantify the current and future size of the inflammatory bowel disease market
Other selected research from the 'Markets' category:
New Opportunities in US Biofuel Market (2006)
This report provides an updated and detailed analysis of the US Biofuel market. The report provides an overview of the global Biofuel market, with exclusive focus on the US markets. Learn More
Seasonal Influenza Vaccines Market Forecast
Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals. Learn More
Other selected research from the 'Gastroenterology' category:
Partneringreview 2006 Vol 2 Ch 8: Gastrointestinal (PR06V2C08)
Inflammatory Bowel Disease Market Forecast
The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. Learn More